← All trials
NCT01327755
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Aug 1, 2013
- Completion date
- Aug 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- The Canadian College of Naturopathic MedicineLead sponsor
- Rwanda Selenium Supplementation Clinical TrialOverall official - principal investigator
- Global Benefit CanadaOverall official - principal investigator
- University of OttawaCollaborator
- Global Benefit CanadaCollaborator
- Wilfrid Laurier UniversityCollaborator
- Kibagabaga District HospitalCollaborator
- Kinyinya Health CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.